CERo Therapeutics Hldgs
(NASDAQ:CERO)
$1.32
-0.09[-6.38%]
At close: Apr 26
$1.32
0[0.00%]
After Hours: 7:39PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

CERo Therapeutics Hldgs Stock (NASDAQ:CERO), Quotes and News Summary

CERo Therapeutics Hldgs Stock (NASDAQ: CERO) stock price, news, charts, stock research, profile.

Open$1.420
Close$1.370
Volume / Avg.94.318K / 1.396M
Day Range1.370 - 1.470
52 Wk Range1.330 - 12.380
Market Cap$19.435M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
34
Short Interest
0.18%
Days to Cover1

Recent News

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.
Avi Kapoor
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results.</
Avi Kapoor
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
About CERo Therapeutics Holdings Inc.
Sector
Health Care
Industry
Biotechnology
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of n...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CERO
VINC

FAQ

Q

How do I buy CERo Therapeutics Hldgs (CERO) stock?

A

You can purchase shares of CERo Therapeutics Hldgs (NASDAQ: CERO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are CERo Therapeutics Hldgs's (CERO) competitors?

A

Other companies in CERo Therapeutics Hldgs’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Serina Therapeutics (AMEX:SER), T2 Biosystems (NASDAQ:TTOO) and Lumos Pharma (NASDAQ:LUMO).

Q

What is the target price for CERo Therapeutics Hldgs (CERO) stock?

A

There is no analysis for CERo Therapeutics Hldgs.

Q

Current Stock Price for CERo Therapeutics Hldgs (CERO)?

A

The stock price for CERo Therapeutics Hldgs (NASDAQ: CERO) is $1.32 last updated April 26, 2024 at 7:39 PM EDT.

Q

Does CERo Therapeutics Hldgs (CERO) pay a dividend?

A

There are no upcoming dividends for CERo Therapeutics Hldgs.

Q

When is CERo Therapeutics Hldgs (NASDAQ:CERO) reporting earnings?

A

CERo Therapeutics Hldgs’s Q1 earnings are confirmed for Monday, May 20, 2024.

Q

Is CERo Therapeutics Hldgs (CERO) going to split?

A

There is no upcoming split for CERo Therapeutics Hldgs.

Q

What sector and industry does CERo Therapeutics Hldgs (CERO) operate in?

A

CERo Therapeutics Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch